We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Aaron Smith, Co-Founder of Unlearn, to talk about how they use digital twins to save resources in clinical trials and fast-track the most promising therapies.

Unlearn increases the statistical power of clinical trials with fewer patients using disease-specific ML models. Leading biopharma companies are applying Unlearn’s technology in real-world clinical trials today. Abbvie is accelerating Clinical Development in Alzheimer’s Disease using Unlearn to reduce control arm size by 33% and reduce time to complete clinical trials by 4+ months.

Unlearn customers design and run smaller RCTs that maintain power or boost it without additional study participants. This approach is qualified by the EMA and aligns with current FDA guidance.

Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

• Tell me about your journey to Unlearn?
• How do you create value for your drug and device customers?
• How do you measure the value?
• What are 3 things you’d like to achieve in the next 12 months?

Now, without further ado, we’re excited to share with you the next episode of the Life Sciences Today podcast.

Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:

• Apple Podcasts
• Spotify
• iHeartRadio
• Amazon Music
• Pandora
• YouTube

Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube.  Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.

If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

Thanks so much for listening!